Cargando…
Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production
Major depressive disorder (MDD) is a leading cause of disability worldwide. A comprehensive understanding of the molecular mechanisms of this disorder is critical for the therapy of MDD. In this study, it is observed that deubiquitinase Mysm1 is induced in the brain tissues from patients with major...
Autores principales: | Zhang, Heyang, Liu, Shuirong, Qin, Qiaozhen, Xu, Zhenhua, Qu, Yannv, Wang, Yadi, Wang, Jianing, Du, Zhangzhen, Yuan, Shanshan, Hong, Shunming, Chang, Zhilin, He, Wenyan, Yan, Xinlong, Lang, Yiran, Tang, Rongyu, Wang, Yan, Zhu, Lingling, Jiang, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811473/ https://www.ncbi.nlm.nih.gov/pubmed/36414403 http://dx.doi.org/10.1002/advs.202204463 |
Ejemplares similares
-
Ectoderm-derived frontal bone mesenchymal stem cells promote traumatic brain injury recovery by alleviating neuroinflammation and glutamate excitotoxicity partially via FGF1
por: Qin, Qiaozhen, et al.
Publicado: (2022) -
miR-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration via Repressing Dkk3
por: Zhao, Changming, et al.
Publicado: (2021) -
miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p/Itgb1/MAPK pathway
por: Huang, Meng, et al.
Publicado: (2022) -
Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation
por: Li, Ping, et al.
Publicado: (2016) -
Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review
por: Fiore, Amanda, et al.
Publicado: (2020)